99% Detection On Early Stage Ovarian Cancer
Imagine a future where all cancer is caught and removed before it gets the chance to metastasize.
New Haven, Conn. — Researchers at Yale School of Medicine have developed a blood test with enough sensitivity and specificity to detect early stage ovarian cancer with 99 percent accuracy.
Results of this new study are published in the February 15 issue of the journal Clinical Cancer Research. The results build on work done by the same Yale group in 2005 showing 95 percent effectiveness of a blood test using four proteins.
